Whitehawk Therapeutics (3350) Q2 2024 Earnings Report
DE:3350 Q2 2024 EPS Results
- Actual EPS
- -EUR 0.48
- Consensus EPS
- -EUR 0.62
- Beat/Miss
- Beat by +EUR 0.13
- One Year Ago EPS
- -EUR 0.60
DE:3350 Q2 2024 Revenue Results
- Actual Revenue
- EUR 5.53M
- Expected Revenue
- EUR 5.54M
- Beat/Miss
- Missed by -EUR 9,849.376
- YoY Revenue Growth
- -0.37%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/07/2024
- Time
- Before Open
- Conference Call
- Wednesday, August 7, 2024
DE:3350 Upcoming Earnings
Whitehawk Therapeutics's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:3350 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:3350 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2026 (Q3) | -0.19- | -0.23 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -0.27-0.18 | -0.68 | 73.68% (+0.50) | |
| May 07, 2026 | 2026 (Q1) | -0.32-0.29 | 1.64 | -117.49% (-1.93) | |
| Mar 12, 2026 | 2025 (Q4) | -0.43-0.30 | -0.6 | 49.25% (+0.30) | |
| Nov 06, 2025 | 2025 (Q3) | 0.06-0.23 | -0.41 | 43.48% (+0.18) | |
| Aug 07, 2025 | 2025 (Q2) | 0.74-0.68 | -0.48 | -40.74% (-0.20) | |
| May 08, 2025 | 2025 (Q1) | -0.411.64 | -0.61 | 369.12% (+2.25) | |
| Mar 18, 2025 | 2024 (Q4) | -0.26-0.60 | -0.54 | -11.67% (-0.06) | |
| Nov 06, 2024 | 2024 (Q3) | -0.41-0.41 | -0.54 | 23.33% (+0.13) | |
| Aug 07, 2024 | 2024 (Q2) | -0.62-0.48 | -0.6 | 19.40% (+0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
